• About
  • Advertise
  • Careers
  • Contact
Monday, December 4, 2023
Irohin Odua
Advertisement
  • Home
  • ABOUT US
    • EDITORIAL TEAM
  • World
  • Politics
  • Contact
  • Donation
No Result
View All Result
  • Home
  • ABOUT US
    • EDITORIAL TEAM
  • World
  • Politics
  • Contact
  • Donation
No Result
View All Result
Irohin Odua
No Result
View All Result
Home News

Coronavirus: Trump offers $1b to German firm for US only vacine

by aisha
March 16, 2020
in News
0
0
SHARES
0
VIEWS
Share on FacebookShare on TwitterWhatsAppEmail

By Kinsley Nderibe

The United States President, Mr Donal Trump has offered $1b to a German company working on a coronavirus vaccine to make it available for exclusive use by Americans, a German newspaper reported on Sunday.

The report monitored by Irohinoodua indicated that Trump approached scientists employed by CureVac, a German pharmaceutical company based in Tuebingen, and tried to lure them to work for the U.S., Welt am Sonntag reported. Mr Trump ancestors are Germans

Trump’s lucrative offer – reportedly of 1 billion dollars – was explicitly made to secure any future vaccine “only for the U.S.,” the newspaper said, citing anonymous sources in the German government. According to the report, the German government has countered the U.S. offer with its own funds in an attempt to keep the company in Germany.

When approached for comment, the German Health Ministry referred dpa to an earlier statement made to the paper: “The government is very keen that a vaccine against the novel coronavirus is developed in Germany and in Europe,” a spokesperson said. “The government is in intensive discussions to that end with the CureVac company,” the spokesperson added.

CureVac is reportedly working with the Paul Ehrlich Institute, a German body responsible for approving vaccines and pharmaceuticals, on a coronavirus vaccine.

In a report due to be published in the Mannheimer Morgen newspaper on Monday, CureVac’s investors said they would never consider working on an exclusive vaccine for the United States.

“We want to develop a vaccine for the whole world and not for individual states,” Christof Hettich, director and co-founder of dievini Hopp BioTech Holding, which is CureVac’s chief investor, told the paper.

 

Previous Post

Govs in fresh strategy to retain Oshimhole as APC Chairman ……party awaits Appeal Court decision today

Next Post

Oshiomole,Court postpones hearing indefinitely

Next Post

Oshiomole,Court postpones hearing indefinitely

  • About
  • Advertise
  • Careers
  • Contact

Copyright © 2023. All Right Reserved

No Result
View All Result
  • Home
  • ABOUT US
    • EDITORIAL TEAM
  • World
  • Politics
  • Contact
  • Donation

Copyright © 2023. All Right Reserved

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist